What Is Thoracentesis for Mesothelioma?

Why Thoracentesis Is Performed

Thoracentesis is one of the most commonly performed procedures for mesothelioma patients. Pleural effusion — the abnormal accumulation of fluid between the lung and the chest wall — occurs in the majority of pleural mesothelioma patients and is often the symptom that leads to initial diagnosis. The fluid compresses the lung, causing progressive shortness of breath, reduced oxygen levels, and chest heaviness. Thoracentesis provides rapid relief by removing this excess fluid.

Thoracentesis serves both therapeutic and diagnostic purposes. Therapeutically, draining a large effusion can provide immediate and significant improvement in breathing. Diagnostically, the drained fluid is sent for cytological analysis, which may reveal mesothelioma cells and help establish or confirm the diagnosis. However, a tissue biopsy is typically needed for a definitive mesothelioma diagnosis.

The Thoracentesis Procedure

Thoracentesis is a relatively simple procedure typically performed at the bedside or in an outpatient clinic. The patient sits upright, leaning slightly forward. The physician uses ultrasound to identify the location and volume of the fluid collection and to guide needle placement. After cleaning the skin and administering local anesthesia, a needle or small catheter is inserted through the chest wall into the pleural space.

The fluid is drained by gravity or gentle suction into collection bottles. Typically, up to 1–1.5 liters are removed in a single session to avoid re-expansion pulmonary edema, a rare but serious complication. The entire procedure usually takes 15–30 minutes. Most patients feel significant breathing improvement within hours of the procedure.

Risks and Limitations

Thoracentesis is generally safe, with a complication rate of less than 5% when performed under ultrasound guidance. Potential risks include pneumothorax (collapsed lung from air entering the pleural space), bleeding, infection, and rarely, injury to the liver or spleen. Pain at the needle insertion site is common but usually mild and temporary.

The primary limitation of thoracentesis is that it provides only temporary relief. In mesothelioma patients, pleural effusion typically reaccumulates within days to weeks, requiring repeated procedures. When effusions recur frequently, more definitive management with pleurodesis or an indwelling pleural catheter is usually recommended.

When to Consider Alternatives

Patients requiring thoracentesis more than once or twice should discuss longer-term options with their medical team. Pleurodesis fuses the pleural layers to prevent fluid reaccumulation. An indwelling pleural catheter (IPC) allows patients to drain fluid at home on a schedule that maintains comfort. The choice depends on the patient’s overall treatment plan, life expectancy, and preferences.

These palliative interventions are an important part of comprehensive mesothelioma palliative care and can significantly improve quality of life throughout treatment.

Financial and Legal Support

Repeated procedures and ongoing symptom management increase the financial burden of mesothelioma. Patients with asbestos-related disease may pursue legal compensation to cover medical costs and other damages. Contact Danziger & De Llano at 1-800-400-1805 for a free case evaluation.